Haichen Pharmaceutical: Audit inquiry letter on the application of Nanjing Haichen Pharmaceutical Co., Ltd. to issue shares to specific targets
Haichen Pharmaceutical: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Haichen Pharmaceutical: 4-1 Legal Opinion (Application Draft)
Haichen Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)
Haichen Pharmaceutical: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Haichen Pharmaceutical: 1-1 Application Instructions (Application Draft)
Haichen Pharmaceutical: 2021 Equity Distribution Implementation Notice
Haichen Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Announcement on the temporary suspension of “N Haichen” intraday trading
Announcement on the listing and trading of shares of Nanjing Haichen Pharmaceutical Co., Ltd. on the GEM
Haichen Pharmaceutical: China Securities Regulatory Commission's approval for the company's initial public offering of shares
No Data